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This study aims to introduce IViST (In Vivo Source Tracking), a novel multi-sensors
dosimetry platform for real-time treatment monitoring in HDR brachytherapy. IViST
is a platform that comprises 3 parts: 1) an optimized and characterized multi-point
plastic scintillator dosimeter (3 points mPSD; using BCF-60, BCF-12, and BCF-
10 scintillators), 2) a compact assembly of photomultiplier tubes (PMTs) coupled
to dichroic mirrors and filters for high-sensitivity scintillation light collection, and
3) a Python-based graphical user interface used for system management and signal
processing. IViST can simultaneously measure dose, triangulate source position, and
measure dwell time. By making 100 000 measurements/s, IViST samples enough data
to quickly perform key QA/QC tasks such as identifying wrong individual dwell time
or interchanged transfer tubes. By using 3 co-linear sensors and planned information
for an implant geometry (from DICOM RT), the platform can also triangulate source
position in real-time. A clinical trial is presently on-going using the IViST system.
Keywords: multi-sensor platform, in vivo source tracking, brachytherapy
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I. INTRODUCTION
In vivo dosimetry (IVD) in brachytherapy (BT) aims to quantify in real-time the agree-
ment between the treatment plan and delivered dose. Presently, BT clinics do not verify
their treatments in real-time because: (a) commercial real- time systems have small signal-
to-noise ratios (SNR), limited time resolution and large measurements uncertainties; (b)
laboratory real-time systems can be cumbersome to operate; (c) detector systems do not
employ robust error detection algorithms, large false positive rate, poor confidence in error
reporting. Several studies1–8 have focused on developing detectors and methods for real-
time source monitoring in BT. The advantages of using plastic scintillator detectors (PSDs)
have been outlined in the literature9,10]. Nevertheless, PSDs are affected by stem effect and
temperature variations11,12. The proper optimization of the optical chain combined with
the implementation of mathematical methods to correct both dependencies on the detector
response, the use of multipoint plastic scintillator detector (mPSD) configuration is suitable
for real-time source tracking in high dose rate (HDR) brachytherapy13–15.
The main goal of this paper is to introduce IViST, as a new multi-sensor dosimetry
platform for real-time plan monitoring in HDR brachytherapy as well as the first end-to-end
application of IViST into the clinical context.
II. IVIST AS A PLATFORM
IViST comprises 3 parts: 1) a 3 points mPSD, 2) a light collection system, and 3) a
Python-based graphical user interface (GUI) for system management and signal processing.
IViST can simultaneously measure dose, triangulate source position, and measure dwell
time.
II.A. Dosimetry system
The optimized dosimetry system consisted of a 1.0 mm-diameter core mPSD (using BCF-
60, BCF-12, and BCF-10 scintillators) coupled to 15 m-long fiber-optic cable Eska GH-4001
from Mitsubishi Rayon Co., Ltd. (Tokyo, Japan). The mPSD fiber was connected to a
data acquisition system consisting of a compact assembly of photomultiplier tubes (PMTs)
coupled with dichroic mirrors and filters to achieve a highly sensitive scintillation light
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collection15. The scintillation light generated inside the mPSD is collected in real-time and
decoupled using multiple spectral bands14,15. The PMTs readout is indenpendant from the
irradiation unit. Signal acquisition is made at a rate of 100 kHz using a data acquisition
board (DAQ) type DAQ NI USB-6216M Series Multifunction from National Instruments
(Austin, USA).
Fig. 1 IViST’s dosimetry system. A detailed list of sub-components can be found in Linares
Rosales et al.16
The design of the in vivo dosimetry system is shown in figure 1. The detector was made
light-tight to avoid environmental light. The mPSD can be inserted into a 24-cm plastic
catheter (Best Medical International, Springfield, VA, USA). In vivo measurements can
be made using a supplemental catheter during HDR brachytherapy. The light collection
apparatus was enclosed into a custom-made box containing the light acquisition system as
well as the DAQ. It is a passive light collection system that does not represent any electrical
risk. The system’s dosimetric performance have been evaluated in HDR brachytherapy,
covering a range of 10 cm of source movement around the sensors15,16. Within a range of
distances of 6 cm from the source, IViST can track the 192Ir source with at least a 1 mm
positional accuracy, and dose agreement with TG43-U117 expected dose within 5 %16. The
detector further exhibited no angular dependence and the system high collection rate allows
for dwell time assessment with a maximum average weighted deviation of 0.33 ± 0.37 s16.
3
II.B. Graphical user interface for dosimetry system control
Figure 2 illustrates the graphical user interface (GUI) of the key software tools available
to control the dosimetry system. The GUI was designed for simple operation by any users.
PyQt5 was used to create the GUI. Figure 3 summarizes the main functionalities of the GUI
and the relationship among them. The softwares main windows give the user access to 2
main modes: Offline and In vivo.
Within Offline tools:
• Signal processing: A measurement file is loaded in this module by the user. Then,
the module allows for easy extraction and manipulation of the raw data previously
collected. It can also be used to extract the statistics associated with each dwell
position (e.g. measured dwell time, mean raw signal, mean dose per dwell).
• System calibration: The module receives a measurement data set, and based on
TG43s expected dose, generates the calibration models for raw signal translation into
a dose value. Among the main features of this module, it allows for dose prediction
with the hyper-spectral approach proposed in14 as well as a Random Forest algorithm
and Neural Network.
• Dosimetry tools: Performs the dosimetric analysis of the collected data. The user
could, for instance, verify the agreement of the measured dose with that expected
from TG43 and calculate the source position for the measured plan. The module also
includes a catheter shift correction feature.
The In Vivo Dosimetry module contains the tools used for real-time data acquisition:
• Voltage acquisition: Collects the raw measurement data from each PMT in volts.
• Dose measurement is a similar to the offline module, excepting that a calibration
data file has to be available in advance.
• Monitor Oncentra prostate plan: Performs real-time tracking of a patient plan
created in Oncentra Prostate (Nucletron, Elekta, Sweden). The module reads the plan
data contained in the *.cha files exported from the TPS, sets the treatment data as
reference and monitors the patient plan in real-time. The system should be calibrated
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Fig. 2 IViSTs graphical user interface. Illustration of some of the available functionalities.
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Fig. 3 IViST’s code’s diagrams.
in advance. The GUI allows for real-time visualization of the measured dose at the
mPSD location as well as the source location.
III. IN VIVO MEASUREMENTS FOR A PROSTATE TREATMENT: FIRST
PATIENT MEASUREMENTS
In vivo dose monitoring was carried out for the first patient enrolled in an IRB approved
protocol. Seventeen treatment catheters were positioned and reconstructed to deliver 15 Gy
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Fig. 4 Source position triangulation results. Heat map of deviations between the planned position
and the triangulated one in a 3D space. The cells in gray correspond to non-programmed dwell
positions.
in a single fraction. An additional catheter devoted to measurements with the mPSD was
introduced in the prostate volume. The mPSDs catheter was also reconstructed, but it was
not used during the dose optimization process in the treatment planning system.
Figure 4 shows the heat map of deviations obtained between the planned source dwell
positions and the results from the triangulation with the mPSD. The x-axis corresponds to
the dwell position index within each catheter, while the y-axis corresponds to the treatment
catheter number. Catheter 8 is not plotted because it corresponds to the catheter dedicated
to measurements with the mPSD. In total, 168 source dwell positions were tracked. As
could be observed in figure 4, in most of the cases, the radial deviations remain below 3 mm.
However, there are some dwell positions with deviations reaching 9 mm. This effect could
be explained by the small source dwell times, 0.1 s (resultant from the dose optimization
process), programmed at dwell-positions. Figure 5 presents the observed radial deviations
as a function of the delivered dwell times for BCF10, BCF12, BCF60 sensors as well as for
the mPSD’s triangulation results. As could be observed in figure 5, for dwell times of 0.1 s,
radial deviations in the order of 6 mm should be expected. IViSTs data is collected at a rate
of 100 kHz but averaged each 0.1 s. Thus a dwell time of 0.1 s makes almost impossible to
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Fig. 5 Scintillator deviation of the expected source-to-dosimeter radial deviations as a function
of the source planned dwell time.
distinguish one single dwell position from the previous/subsequent one, leading to a failed
triangulation for those locations. However, for any dwell-time of 0.5 s or more, the weighted
average is 2.17 ± 1.15 mm.
Figure 6 shows the mean deviations between the measured dwell times for our mPSD sys-
tem and the planned ones. The measured dwell times at all the distances to the source were
agreement with the planned dwell time to better than 0.17 s. The overall average difference
obtained was 0.06±0.04 s. Larger deviations were observed for dwell positions with dwell
times inferior to 0.5 s, especially for those positions at long distances from the scintillators’
effective volumes. Even though the longest mPSD-to-source distance measured for this clin-
ical case was 55 mm, the high gradient field characteristic of the 192Ir source allowed to us
obtain a sharp pulse of signal and, as a consequence, proper differentiation of the signal
from one position to the subsequent one. A similar dwell time analysis was performed by
Linares Rosales16 et al. through in-water measurements during HDR brachytherapy. They
reported a maximum deviation of 0.33 ± 0.37 s for a range of mPSD-to-source distance up
to 10 cm. However, for the same range of distance to the explored in this paper, the results
are equivalents16.
IV. CONCLUSIONS
A novel, multi-sensor dosimetric system was optimized for HDR brachytherapy in vivo
dosimetry and enabled measurements over a wide range of clinically relevant dose rate. The
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Fig. 6 Deviation of mPSD measured dwell times from planned dwell times as function of planned
dwell-time intervals.
system presented allows real-time dose, source position and dwell-time measurements. It has
numerous potential in vivo QA/QC applications beyond the currently available commercial
dosimeters and build on its widely-known intrinsic energy independence and water equiv-
alence properties. The first clinical in vivo case measured with iViST has been presented
here and the clinical trial is on-going.
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